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alitis is caused by serum antibodies against NMDAR, and
is often associated with tumors [1]. Its symptoms include
psychosis, seizures and disturbance of consciousness, all of
which resemble the symptoms induced by NMDA antag-
onists, such as ketamine. We report a patient with anti-
NMDAR encephalitis, and we had difficulty treating the
patient because no primary tumor was found.
A 57-year-old woman, who had a cough and fever,
developed to status epilepticus, and consciousness distur-
bance. Examinations revealed elevated anti-NMDAR
antibodies, but no obvious primary tumor could be found
with a CT scan. However, fluorodeoxyglucose positron
emission tomography showed an accumulation of fluores-
cence in a right enlarged obturator lymph node (Fig. 1,
Supplementary material), indicating augmented metabo-
lism, and lymph node removal was scheduled. After epi-
dural catheter placement, anesthesia was induced with
propofol, and the trachea was intubated. Anesthesia was
maintained with 60 % nitrous oxide and 1.5 % sevoflurane
with epidural anesthesia. The surgery was completed
without complications. After tracheal extubation, the
patient was transferred to the intensive care unit. The
patient’s postoperative course was uneventful. Her lymph
node was histopathologically normal, but we postulated
that the lymph node would produce ectopic NMDAR. The
patient’s level of consciousness improved gradually.
There are some anesthetic drugs that serve as NMDAR
antagonists, such as ketamine and nitrous oxide. Pryzbyl-
kowski et al. [2] have recommended avoiding such drugs
for anesthesia in a patient with anti-NMDAR encephalitis,
and we should not have used nitrous oxide for anesthesia.
In conclusion, we encountered a patient with anti-
NMDAR encephalitis without a responsible tumor, but
removal of a metabolically active enlarged lymph node
markedly improved the symptoms.
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